CNS Pharmaceuticals, Inc. Common Stock, Value, Issued
CNS Pharmaceuticals, Inc. (CNSP) had Common Stock, Value, Issued of $2.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-08-12
- 2026-06-30: Common Stock, Value, Issued $2.00K.
- 2026-03-31: Common Stock, Value, Issued $811.00.
- 2025-12-31: Common Stock, Value, Issued $1.00K; Common Stock, Value, Issued as first filed $633.00.
- 2025-09-30: Common Stock, Value, Issued $574.00.
| Period end | Common Stock, Value, Issued | Common Stock, Value, Issued as first filed |
|---|---|---|
| 2026-06-30 | $2.00K 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $811.00 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $1.00K 10-Q · filed 2026-08-12 | $633.00 10-K · filed 2026-03-31 |
| 2025-09-30 | $574.00 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $504.00 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $2.94K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $118.00 10-K · filed 2026-03-31 | $1.41K 10-K · filed 2025-03-31 |
| 2024-09-30 | $33.45K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $1.44K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $10.67K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $2.00 10-K · filed 2025-03-31 | $6.21K 10-K · filed 2024-04-01 |
| 2023-09-30 | $4.21K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $4.14K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $2.23K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $1.62K 10-K · filed 2024-04-01 | |
| 2022-09-30 | $40.03K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $40.03K 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $40.03K 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $949.00 10-K · filed 2023-03-31 | $27.93K 10-K · filed 2022-03-03 |
| 2021-09-30 | $27.46K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $27.38K 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $25.35K 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $23.86K 10-K · filed 2022-03-03 | |
| 2020-09-30 | $16.65K 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $16.45K 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $16.45K 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $16.45K 10-K · filed 2021-02-12 | |
| 2019-09-30 | $13.59K 10-Q · filed 2019-12-20 | |
| 2018-12-31 | $12.70K 10-K · filed 2020-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |